Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus (Q40374118)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 12 November 2009

Language	Label	Description	Also known as
English	Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus	scientific article published on 12 November 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Farshad Guirakhoo

8

object named as

Farshad Guirakhoo

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

author name string

Alexander A Rumyantsev

1

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Zhen-xi Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Qing-sheng Gao

3

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Nicolas Moretti

4

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Nathan Brown

5

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Harold Kleanthous

6

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Simon Delagrave

7

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Marc S Collett

9

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Konstantin V Pugachev

10

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

language of work or name

0 references

publication date

12 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

396

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

329-338

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

Development of Sindbis Viruses Encoding nsP2/GFP Chimeric Proteins and Their Application for Studying nsP2 Functioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Ab and T cell epitopes of influenza A virus, knowledge and opportunities

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

In situ reactions of monoclonal antibodies with a viable mutant of Murray Valley encephalitis virus reveal an absence of dimeric NS1 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

The NS1 protein of tick-borne encephalitis virus forms multimeric species upon secretion from the host cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Role of the hypervariable hinge region of phosphoprotein P of vesicular stomatitis virus in viral RNA synthesis and assembly of infectious virus particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Universal influenza A M2e-HBc vaccine protects against disease even in the presence of pre-existing anti-HBc antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

A "universal" human influenza A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Random insertion mutagenesis of sindbis virus nonstructural protein 2 and selection of variants incapable of downregulating cellular transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Heterologous gene expression by infectious and replicon vectors derived from tick-borne encephalitis virus and direct comparison of this flavivirus system with an alphavirus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Loss of dimerisation of the nonstructural protein NS1 of Kunjin virus delays viral replication and reduces virulence in mice, but still allows secretion of NS1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Construction and applications of yellow fever virus replicons.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Molecular biology of flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

A live, attenuated recombinant West Nile virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Functional characterization of the Sindbis virus E2 glycoprotein by transposon linker-insertion mutagenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

A universal influenza A vaccine based on the extracellular domain of the M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Traditional and novel approaches to flavivirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

A novel method for cloning of non-cytolytic viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Mutation of E1 glycoprotein of classical swine fever virus affects viral virulence in swine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Yellow fever 17D as a vaccine vector for microbial CTL epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

West Nile Virus Nonstructural Protein 1 Inhibits TLR3 Signal Transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a glycosylation-dependent fashion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2009.10.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIROL.2009.10.033

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40374118&oldid=1896426208"